China Pharmaceutical Enterprises Technological Innovation Ability Evaluation--Emprical Study on China's State-owned Pharmaceutical Company

机译：中国医药企业技术创新能力评价-中国国有医药公司的实证研究

获取原文

获取原文并翻译 | 示例

页面导航

摘要
著录项
相似文献
相关主题

摘要

This paper has constructed a new evaluation system to evaluate the technological innovation ability of China's pharmaceutical companies and used the AHP analysis method to evaluate the system. According to the evaluation results we have identifed the key factors of China's pharmaceutical enterprises' technological innovation ability. And then we made an empirical study on the evaluation results by using the relevent objective data in the statistical yearbook on science & technology. On this basis, we reached some reliable conclusions.

机译：本文构建了一种新的评价体系，用于评价我国制药企业的技术创新能力，并采用层次分析法对其进行评价。根据评估结果，我们确定了中国制药企业技术创新能力的关键因素。然后，我们使用《科学技术统计年鉴》中的相关客观数据对评估结果进行了实证研究。在此基础上，我们得出了一些可靠的结论。

著录项

来源
《Comprehensive evaluation of economy and society with statistical science.》|2010年|p.64-68|共5页
会议地点 Weihai(CN);Weihai(CN)
作者
YONG Lanli; HU Songyu;
展开▼
作者单位

Business School, Hebei Normal University, Shijiazhuang, Hebei, P.R.China, 050091;

Department of Business Administration, Shijiazhuang Vocational Collegeof Lawand Business,Shijiazhuang, Hebei, P.R.China, 050091;

展开▼
会议组织
原文格式 PDF
正文语种 eng
中图分类经济统计学;经济统计学;
关键词
technological innovation; pharmaceutical companies; AHP; empirical study;

机译：技术创新；制药公司; AHP;实证研究;

相似文献

外文文献
中文文献
专利

1. A Hard-Won Victory-Tianjin Pharmaceuticals Corp.Sets an Example for China’s State-owned Enterprises [J] . 今日中国：英文版 . 1999,第009期

机译：来之不易的胜利天津医药集团为中国国有企业树立榜样
2. On Choices of Innovation Strategy of Chinese Pharmaceutical Enterprises from Perspective of “Wise Pig Game” [J] . Shuzhen Chu, Zhijun Han International Journal of Business and Management . 2009,第4期

机译：从“智慧比赛”的角度看中国制药企业创新策略的选择
3. Empirical Study on the Transparency of Security Risk Information in Chinese Listed Pharmaceutical Enterprises Based on the ANP-DS Method [J] . Wang Jining, Guo Chong, Chen Tingqiang Journal of healthcare engineering. . 2020,第1期

机译：基于ANP-DS方法的中国上市药品企业安全风险信息透明度的实证研究
4. China Pharmaceutical Enterprises Technological Innovation Ability Evaluation--Emprical Study on China's State-owned Pharmaceutical Company [C] . YONG Lanli, HU Songyu International Institute of Statistics Management Engineering Symposium . 2010

机译：中国制药企业技术创新能力评估 - 中国国有制药公司的Emprice研究
5. Developing a Strategic Policy Choice Framework for Technological Innovation: Case of Chinese Pharmaceuticals [D] . Chan, Leong 2013

机译：制定技术创新战略政策选择框架：以中国制药业为例
6. Empirical Study on the Transparency of Security Risk Information in Chinese Listed Pharmaceutical Enterprises Based on the ANP-DS Method [O] . Jining Wang, Chong Guo, Tingqiang Chen 2020

机译：基于ANP-DS方法的中国上市制药企业安全风险信息透明度的实证研究
7. Research on Salary Management of Large State-owned Listed Pharmaceutical Enterprises—China Resources Sanjiu as an Example [O] . Lin-lin LIU 2020

机译：大型国有上市药品企业薪酬管理 - 中国资源三九为例

China Pharmaceutical Enterprises Technological Innovation Ability Evaluation--Emprical Study on China's State-owned Pharmaceutical Company

摘要

著录项

相似文献

相关主题

期刊订阅